Cord blood stem cells have attracted enormous interest in recent years due to several factors including relative ease of collection/processing/storage, improved potential in proliferative and differentiation capacity, as well as reported enhancements in patient engraftment and reduction in GVHD. These benefits have created a specialized banking industry and a market need for use of cord blood as a source for clinical cell-based therapies. With the public becoming more and more educated on stem cells the market is poised for major expansion in the coming few years.

In order to capture this market expansion TotipotentSC provides a full service "compliance focused" approach to assist you from concept through operational launch.  Our senior partners have direct experience with over 20 cord blood banks internationally and can guide you to the same success. We can provide the guidance and expertise to ensure that you comply with the necessary regulatory requirements on both local and international fronts.